Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Fifth Affiliated Hospital,Sun Yat-sen University, Zhuhai, Guangdong, China
Contact: Study coordinator (Rui You) · your5@mail.sysu.edu.cn · 13580439820

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PDT For Induction Therapy For Head And Neck Cancer

Squamous Cell Carcinoma · Head and Neck Cancer Squamous Cell Carcinoma · Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Boston, United States · Boston, United States

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Pittsburgh, United States

Low-Dose Weekly vs High-Dose Cisplatin

Locally Advanced Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)Recruiting

Hamilton, Canada · London, Canada

Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China